Black Hawk Acquisition (BKHAU) Return on Assets ROA from the third quarter of 2026 to third quarter of 2025 and for the year 2026, Average High and Low, Fundamental Ratios from Aug 31 2026 to Aug 31 2025 - CSIMarket
CSIMarket
 


Black Hawk Acquisition Corporation  (NASDAQ: BKHAU)


Black Hawk Acquisition's ROA from the third quarter of 2026 to the third quarter of 2025 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Black Hawk Acquisition's ROA in the third quarter of 2026?
Black Hawk Acquisition Corporation achieved a return on average assets (ROA) of 5.14 % in its third quarter of 2026, this is above BKHAU's average return on assets of 2.01%.
Black Hawk Acquisition Corporation assets over the 12 months ending in its third quarter of 2026 are valued at $25 million

ROA has improved compared to 1.55% in the second quarter of 2026, due to net income growth.

However, within the Healthcare sector 148 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Aug 31 2026 quarter, so far to 1783, from total ROA ranking in the second quarter of 2026 at 1943.

What is ROA?



Return On Assets (Aug 31 2026)
III. Quarter
(May 31 2026)
II. Quarter
(Feb 28 2026)
I. Quarter
(Nov 30 2025)
IV. Quarter
(Aug 31 2025)
III. Quarter
Y / Y Total Assets Change 15.16 % -64.62 % -65.62 % -66.9 % -67.71 %
Y / Y Net Income Change 596.07 % -82.92 % -78.77 % - -82.53 %
Net Income (TTM) in million 1 0 1 1 2
Return On Assets (TTM) 5.14 % 1.55 % 2.24 % 2.77 % 3.47 %
BKHAU's Total Ranking # 1783 # 1943 # 2516 # 2086 # 2223
Total Assets (TTM) in million 27 26 25 24 23
Seq. Total Assets Change 2.54 % 4.26 % 3.95 % 3.62 % -68.49 %
Seq. Net Income Change 1108.53 % -36.39 % - - -70.34 %



Return On Assets Company Ranking
Within: No.
Industry # 16
Sector # 149
Overall # 1137

Return On Assets Statistics
High Average Low
5.19 %
2.01 %
0.23 %
(Aug 31 2026)   (Aug 31 2025)





Financial Statements
Black Hawk Acquisition's Assets $ 27 million BKHAU's Balance sheet
Black Hawk Acquisition's Income $ 1 million Quarterly BKHAU's Income Statement
BKHAU's Income by Division See BKHAU's Income by Division



Annual Return On Assets (Nov 30 2025)
FY 2025
(Nov 30 2024)
FY 2024

FY

FY

FY
Y / Y Total Assets Change -66.9 % - - - -
Total Assets in million 24 72 0 0 0
Y / Y Net Income Change -30.6 % - - - -
Net Income in million 1 2 0 0 0
Annual Return On Assets 5.57 % 2.66 % - - -




Comment on BKHAU's ROA in the fiscal year ending 2025
Despite deterioration in net income of -30.6 % to $1.33 million, Black Hawk Acquisition's ROA improved in the fiscal year2025 to 5.57 % compared to previous year, as the value of BKHAU's assets decline even faster to $23.88 million, from $23.88 a year before.


More Return On Assets Ratios
BKHAU's' Return on Assets at Yahoo Finance
Biotechnology & Pharmaceuticals Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
BKHAU's Roa Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for BKHAU's Competitors
Subscribers only: Roa for Black Hawk Acquisition's Suppliers
Subscribers only: Return On Assets for BKHAU's Customers

You may also want to know
BKHAU's Roi BKHAU's Inventory Turnover Ratio BKHAU's Growth Rates BKHAU's Dividend Comparisons
BKHAU's Profitability Ratios BKHAU's Asset Turnover Ratio BKHAU's Dividend Growth
BKHAU's Roe BKHAU's Valuation Ratios BKHAU's Financial Strength Ratios BKHAU's Dividend Payout Ratio



Companies with similar Return On Assets at Aug 31 2026, within Healthcare Sector ROA
Neurocrine Biosciences Inc   13.69 %
Illumina Inc   13.43 %
Healthcare Services Group Inc   12.79 %
Kiniksa Pharmaceuticals International Plc  12.64 %
Alpha Pro Tech Ltd   12.46 %
Tenet Healthcare Corp  12.39 %
Hca Healthcare Inc   11.73 %
Carlisle Companies Incorporated  11.72 %
Regeneron Pharmaceuticals Inc   11.50 %
Lantheus Holdings Inc   11.43 %
Msa Safety Inc  11.01 %
Encompass Health Corporation  10.99 %
Inspire Medical Systems inc   10.89 %
Transmedics Group Inc   10.67 %
Bristol myers Squibb Company  10.47 %
Lemaitre Vascular Inc   10.28 %
Beone Medicines Ltd   10.23 %
Amgen Inc   10.02 %
Bio rad Laboratories Inc   9.88 %
3m Company  9.60 %
Bioventus Inc   9.47 %
Sanuwave Health Inc   9.05 %
Medinotec Inc   8.67 %
Tactile Systems Technology Inc   8.53 %
Penumbra Inc  8.13 %
Johnson and Johnson  8.06 %
Pacific Health Care Organization Inc  7.83 %
Boston Scientific Corporation  7.82 %
Ani Pharmaceuticals Inc  7.77 %
Stryker Corp  7.66 %


Date modified: 2026-10-07T15:05:32+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.